Related Experiment Videos
[Pneumonia: etiologic diagnosis and therapy in general practice]
1Unité de bactériologie médicale, CHUV, Lausanne.
Therapeutische Umschau. Revue Therapeutique
|April 1, 1992
Summary
Community-acquired pneumonia in non-immunocompromised adults often involves atypical agents. Macrolides are recommended for empirical therapy due to their broad-spectrum activity against common pathogens.
Area of Science:
- Infectious Diseases
- Microbiology
- Pulmonology
Context:
- Community-acquired pneumonia (CAP) is common, typically with good prognosis.
- Etiology in non-immunocompromised adults includes classical bacteria and atypical agents.
- Clinical presentation and initial diagnostics often do not pinpoint the causative agent.
Purpose:
- To review the epidemiology and diagnostic challenges of CAP.
- To guide empirical antibiotic selection for CAP in non-immunocompromised adults.
Summary:
- CAP is frequently caused by a mix of bacterial and atypical pathogens.
- Accurate etiological diagnosis is often difficult and delayed.
- Empirical treatment should consider patient factors and likely pathogens.
Impact:
- Macrolide antibiotics (e.g., erythromycin) are effective empirical choices.
- Broad-spectrum coverage addresses common bacterial, atypical, and Legionella species.
- Timely, appropriate empirical therapy improves patient outcomes for CAP.